Physician profile
Thomas K Lee
NPI 1194779041
$749.32
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2021: $297.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aesculap Implant Systems, LLC | $406.06 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $116.12 | 2019 | |
| Electronic Waveform Lab, INC. | $107.97 | 2019 | |
| Pacira Therapeutics, INC. | $32.79 | 2019 | |
| Stryker Corporation | $22.21 | 2019 | |
| Amgen INC. | $20.71 | 2021 | |
| Collegium Pharmaceutical, INC. | $19.26 | 2019 | |
| Shionogi INC | $12.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.